Dr. Roshan Bashir, M.D

NPI: 1104838515
Total Payments
$61,004
2024 Payments
$142.32
Companies
21
Transactions
243
Medicare Patients
852
Medicare Billing
$90,509

Payment Breakdown by Category

Other$49,710 (81.5%)
Travel$6,402 (10.5%)
Food & Beverage$4,891 (8.0%)
Education$1.56 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $49,710 23 81.5%
Travel and Lodging $6,402 23 10.5%
Food and Beverage $4,891 195 8.0%
Education $1.56 2 0.0%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $40,561 62 $0 (2024)
Allergan Inc. $7,834 53 $0 (2019)
Synergy Pharmaceuticals Inc $6,693 17 $0 (2018)
Boston Scientific Corporation $3,727 12 $0 (2024)
Covidien LP $488.04 4 $0 (2018)
Janssen Biotech, Inc. $325.66 15 $0 (2019)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $251.44 15 $0 (2019)
IRONWOOD PHARMACEUTICALS, INC $167.75 5 $0 (2020)
Valeant Pharmaceuticals North America LLC $157.27 8 $0 (2017)
Gilead Sciences, Inc. $149.97 11 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2024 $142.32 5 ABBVIE INC. ($101.11)
2022 $58.80 1 ABBVIE INC. ($58.80)
2021 $7,248 6 AbbVie Inc. ($7,248)
2020 $5,149 5 AbbVie Inc. ($5,116)
2019 $27,303 60 AbbVie, Inc. ($25,116)
2018 $12,126 85 Synergy Pharmaceuticals Inc ($4,164)
2017 $8,977 81 Allergan Inc. ($3,975)

All Payment Transactions

243 individual payment records from CMS Open Payments — Page 1 of 10

Date Company Product Nature Form Amount Type
12/03/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $34.27 General
Category: IMMUNOLOGY
08/28/2024 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $34.16 General
Category: IMMUNOLOGY
07/23/2024 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $32.68 General
Category: IMMUNOLOGY
01/25/2024 AIMMUNE THERAPEUTICS, INC. ZENPEP (Drug) Food and Beverage In-kind items and services $19.60 General
Category: ENDOCRINE PANCREATIC INSUFFICIENCY
01/05/2024 Boston Scientific Corporation VersaCross Access Solution (Device) Food and Beverage In-kind items and services $21.61 General
Category: VersaCross Access Solution_ICG
02/24/2022 ABBVIE INC. CREON (Drug) Travel and Lodging In-kind items and services $58.80 General
Category: ENDOCRINOLOGY
11/08/2021 AbbVie Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,500.00 General
10/27/2021 AbbVie Inc. Food and Beverage In-kind items and services $101.60 General
10/13/2021 AbbVie Inc. CREON (Drug) Travel and Lodging In-kind items and services $28.00 General
Category: ENDOCRINOLOGY
08/03/2021 AbbVie Inc. CREON (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,500.00 General
Category: ENDOCRINOLOGY
07/28/2021 AbbVie Inc. CREON (Drug) Food and Beverage In-kind items and services $116.65 General
Category: ENDOCRINOLOGY
07/28/2021 AbbVie Inc. CREON (Drug) Food and Beverage In-kind items and services $1.69 General
Category: ENDOCRINOLOGY
12/15/2020 AbbVie Inc. CREON (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,500.00 General
Category: ENDOCRINOLOGY
11/20/2020 Boston Scientific Corporation EXALT MODEL D CONTROLLER (Device) Food and Beverage In-kind items and services $13.94 General
Category: THERAPEUTIC IMAGING
03/01/2020 IRONWOOD PHARMACEUTICALS, INC Linzess (Drug), GIVLAARI Food and Beverage Cash or cash equivalent $18.68 General
Category: GI
02/03/2020 AbbVie Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,500.00 General
01/29/2020 AbbVie Inc. Food and Beverage In-kind items and services $116.46 General
11/15/2019 AbbVie, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,500.00 General
11/13/2019 Allergan Inc. ZENPEP (Drug) Food and Beverage In-kind items and services $4.49 General
Category: CYSTIC FIBROSIS
11/05/2019 AbbVie, Inc. Food and Beverage In-kind items and services $93.28 General
09/30/2019 PFIZER INC. XELJANZ (Drug) Food and Beverage In-kind items and services $18.02 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
09/05/2019 PFIZER INC. XELJANZ (Drug) Food and Beverage In-kind items and services $14.28 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
05/28/2019 Gilead Sciences, Inc. Food and Beverage In-kind items and services $12.41 General
05/21/2019 Boston Scientific Corporation SPYGLASS (Device) Food and Beverage In-kind items and services $144.45 General
Category: BILIARY DEVICES
05/16/2019 AbbVie, Inc. Travel and Lodging In-kind items and services $151.42 General

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 4 53 54 $17,720 $4,242
2021 14 417 456 $244,856 $51,302
2020 11 382 407 $133,021 $34,965
Total Patients
852
Total Services
917
Medicare Billing
$90,509
Procedure Codes
29

All Medicare Procedures & Services

29 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99204 New patient office or other outpatient visit, 45-59 minutes Facility 2023 15 15 $6,900 $1,624 23.5%
99203 New patient office or other outpatient visit, 30-44 minutes Facility 2023 14 14 $3,928 $962.64 24.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 11 12 $3,978 $954.24 24.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2023 13 13 $2,914 $701.48 24.1%
45380 Biopsy of the large bowel using an endoscope (colonoscopy) Facility 2021 70 71 $49,700 $10,098 20.3%
99204 New patient outpatient visit, total time 45-59 minutes Facility 2021 65 65 $29,018 $6,887 23.7%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 62 75 $24,235 $5,959 24.6%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 25 46 $15,732 $4,007 25.5%
43242 Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using an endoscope Facility 2021 16 17 $15,980 $3,871 24.2%
43239 Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope Facility 2021 58 60 $28,380 $3,685 13.0%
45385 Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare Facility 2021 17 17 $14,824 $3,652 24.6%
45378 Diagnostic examination of the colon (large bowel) using an endoscope(colonoscopy); high risk Facility 2021 23 24 $15,312 $3,067 20.0%
43264 Removal of stone or debris from bile or pancreatic duct using a flexible endoscope via mouth Facility 2021 11 11 $19,305 $2,362 12.2%
43259 Ultrasound examination of esophagus, stomach and/or upper small bowel using an endoscope Facility 2021 11 11 $8,492 $2,159 25.4%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 12 12 $7,992 $2,029 25.4%
43248 Insertion of guide wire with dilation of esophagus using an endoscope Facility 2021 13 13 $7,345 $1,577 21.5%
99203 New patient outpatient visit, total time 30-44 minutes Facility 2021 20 20 $5,497 $1,278 23.2%
99213 Established patient outpatient visit, total time 20-29 minutes Facility 2021 14 14 $3,044 $669.90 22.0%
99204 New patient office or other outpatient visit, typically 45 minutes Facility 2020 84 84 $22,468 $7,221 32.1%
45380 Biopsy of large bowel using an endoscope Facility 2020 47 48 $33,600 $6,147 18.3%
45385 Removal of polyps or growths of large bowel using an endoscope Facility 2020 20 21 $17,892 $4,757 26.6%
99214 Established patient office or other outpatient, visit typically 25 minutes Facility 2020 66 73 $10,886 $4,550 41.8%
43239 Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope Facility 2020 46 48 $23,191 $3,439 14.8%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2020 23 34 $7,897 $2,998 38.0%
99203 New patient office or other outpatient visit, typically 30 minutes Facility 2020 32 32 $6,490 $1,995 30.7%

About Dr. Roshan Bashir, M.D

Dr. Roshan Bashir, M.D is a Gastroenterology healthcare provider based in Washington, District of Columbia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104838515.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Roshan Bashir, M.D has received a total of $61,004 in payments from pharmaceutical and medical device companies, with $142.32 received in 2024. These payments were reported across 243 transactions from 21 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($49,710).

As a Medicare-enrolled provider, Bashir has provided services to 852 Medicare beneficiaries, totaling 917 services with total Medicare billing of $90,509. Data is available for 3 years (2020–2023), covering 29 distinct procedure/service records.

Practice Information

  • Specialty Gastroenterology
  • Other Specialties Gastroenterology
  • Location Washington, DC
  • Active Since 08/13/2006
  • Last Updated 05/08/2019
  • Taxonomy Code 207RG0100X
  • Entity Type Individual
  • NPI Number 1104838515

Products in Payments

  • Creon (Drug) $11,931
  • Trulance (Drug) $6,693
  • CREON (Drug) $5,205
  • ZENPEP (Drug) $3,202
  • VIBERZI (Drug) $2,916
  • LINZESS (Drug) $1,884
  • GENERAL BILIARY DEVICES (Device) $1,878
  • DREAMTOME (Device) $1,500
  • Manometry (Device) $440.16
  • STELARA (Biological) $262.78
  • XIFAXAN (Drug) $259.46
  • SPYGLASS (Device) $186.13
  • Mavyret (Drug) $140.52
  • Cimzia (Drug) $115.42
  • XELJANZ (Drug) $100.52
  • CLENPIQ (Drug) $89.93
  • ACQUIRE (Device) $82.63
  • UCERIS (Drug) $73.62
  • RINVOQ (Biological) $68.43
  • Viekira (Drug) $64.46

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Gastroenterology Doctors in Washington